Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BR 101 - Byterna Therapeutics

Next Previous
Drug Profile

BR 101 - Byterna Therapeutics

Alternative Names: BR-101 - Byterna Therapeutics; In vivo BCMA/CD19 bispecific CAR-T cell therapy - Byterna Therapeutics; In vivo BCMA/CD19 targeting CAR-T cell therapy - Byterna Therapeutics

Latest Information Update: 27 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Byterna Therapeutics
  • Class Antineoplastics; Circular RNA; Gene therapies; Immunotherapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Multiple myeloma

Most Recent Events

  • 27 Apr 2026 Preclinical trials in Multiple myeloma in China (IV), prior to April 2026
  • 17 Apr 2026 Byterna Therapeutics plans a phase I trial for Multiple myeloma (Second-line therapy or greater) in China, in April 2026 (NCT07537049)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top